Moderna CEO Talks New Drugs

Ross Gerber, co-founder and CEO of Gerber Kawasaki Wealth and Investment Management, says the valuation for Walt Disney Co. "makes no sense" and it's time for a change there. He speaks with Bloomberg's Carol Massar and Tim Stenovec See omnystudio.com/listener for privacy informat ...  Show more

Cathie Wood, CEO of ARK Investment Management, speaks on her SpaceX holdings and ETF funds. She speaks with Bloomberg's Katie Griefeld and Eric Balchunas. See omnystudio.com/listener for privacy information. 

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

Jennifer Rie, Senior Litigation Analyst for Bloomberg Intelligence, gives the latest on Apple and Google's legal woes. Florian Brand, CEO and Co-Founder of Atai, discusses company earnings and biotech sector outlook. RJ Gallo, Senior Portfolio Manager of Fixed Income and Head of ...  Show more

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Fallon Company CEO Michael Fallon discusses the multi-billion-dollar development of Nashville, TN’s East Bank. Glenn Fishback, Co-Founder and CEO of Shopsense AI, talks about the media platform that allows cons ...  Show more